Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $9.10 Analyst target: $47.23 Upside: 419.01%
Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.